436 related articles for article (PubMed ID: 20736231)
21. Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Anesthesiology; 2006 Apr; 104(4):718-23. PubMed ID: 16571967
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
Takeda J; Iwasaki H; Otagiri T; Katoh T; Shingu K; Obara H; Nakatsuka H; Tomiyama Y; Kasaba T
Masui; 2014 Oct; 63(10):1083-8. PubMed ID: 25693333
[TBL] [Abstract][Full Text] [Related]
23. Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex.
Unterbuchner C; Ziegleder R; Graf B; Metterlein T
Acta Anaesthesiol Scand; 2015 Apr; 59(4):536-40. PubMed ID: 25582520
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy and safety of sugammadex (Org 25969) in reversing moderate neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
Takeda J; Iwasaki H; Yamakage M; Ozaki M; Kawamata M; Hatano Y; Yorozuya T; Miyakawa H; Kanmura Y
Masui; 2014 Oct; 63(10):1075-82. PubMed ID: 25693332
[TBL] [Abstract][Full Text] [Related]
25. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
[TBL] [Abstract][Full Text] [Related]
26. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
[TBL] [Abstract][Full Text] [Related]
27. Role of rocuronium and sugammadex in rapid sequence induction in pregnancy.
McGuigan PJ; Shields MO; McCourt KC
Br J Anaesth; 2011 Mar; 106(3):418-9; author reply 419-20. PubMed ID: 21317233
[No Abstract] [Full Text] [Related]
28. The use of sugammadex in a patient with myasthenia gravis.
Unterbuchner C; Fink H; Blobner M
Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
[TBL] [Abstract][Full Text] [Related]
29. Neuromuscular transmission: new concepts and agents.
de Boer HD
J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537
[TBL] [Abstract][Full Text] [Related]
30. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex.
Yoshida F; Suzuki T; Kashiwai A; Furuya T; Konishi J; Ogawa S
Acta Anaesthesiol Scand; 2012 Jan; 56(1):83-7. PubMed ID: 22103864
[TBL] [Abstract][Full Text] [Related]
31. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
[TBL] [Abstract][Full Text] [Related]
32. Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block.
Pavoni V; Gianesello L; Martinelli C; Horton A; Nella A; Gori G; Simonelli M; De Scisciolo G
J Clin Anesth; 2016 Sep; 33():14-9. PubMed ID: 27555126
[TBL] [Abstract][Full Text] [Related]
33. Use of sugammadex in patients with a history of pulmonary disease.
Amao R; Zornow MH; Cowan RM; Cheng DC; Morte JB; Allard MW
J Clin Anesth; 2012 Jun; 24(4):289-97. PubMed ID: 22608583
[TBL] [Abstract][Full Text] [Related]
34. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.
Gaszynski T; Szewczyk T; Gaszynski W
Br J Anaesth; 2012 Feb; 108(2):236-9. PubMed ID: 22012861
[TBL] [Abstract][Full Text] [Related]
35. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report.
Kim JE; Chun HR
Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578
[TBL] [Abstract][Full Text] [Related]
36. [Insufficient sugammadex effect in an obese pregnant woman undergoing cesarean section under general anesthesia].
Kayashima K; Sozen R; Okura D
Masui; 2014 Feb; 63(2):188-90. PubMed ID: 24601116
[TBL] [Abstract][Full Text] [Related]
37. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.
Weekes G; Hayes N; Bowen M
Int J Obstet Anesth; 2010 Jul; 19(3):333-6. PubMed ID: 20627694
[TBL] [Abstract][Full Text] [Related]
38. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.
Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E
Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915
[TBL] [Abstract][Full Text] [Related]
39. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
[TBL] [Abstract][Full Text] [Related]
40. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
